NCT04781556

Brief Summary

Osteoporosis is a bone disease characterized by a decrease in bone density with deterioration of the micro-architecture and the appearance of bone fragility, responsible for an increased risk of fractures. The most common osteoporotic fractures are spinal, wrist and femoral neck fractures. Osteoporosis affects 22.7% of women and 6.9% of men in France. Each year, around 8.9 million fragility fractures are identified worldwide, with an incidence in France in 2017 of 382,000 patients in France in 2017. The economic impact, the functional consequences and the quality of life of patients with osteoporosis, fracture or not, have been widely described in the literature in recent years. There is indeed a great alteration in the mobility, functional capacities and overall quality of life of these patients, measured by composite scores such as Short Form-36 (SF-36), EuroQol 5 Dimensions (EQ-5D) , the Health-related quality of life (HRQoL), or more specifically for osteoporosis, osteoporososis quality of life questionnaire (OQLQ) or its shortened version OLQ, the osteoporosis assessment questionnaire (OPAQ), the Quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO) (specific for vertebral fractures), etc. However, few studies have focused on the repercussions of osteoporotic fractures at work, because this pathology affects more elderly subjects (\> 65 years old) and therefore retirees.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
121

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 26, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2019

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 21, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 1, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 4, 2021

Completed
Last Updated

March 9, 2021

Status Verified

March 1, 2021

Enrollment Period

3 months

First QC Date

March 1, 2021

Last Update Submit

March 5, 2021

Conditions

Keywords

osteoporotic fracturesworkquality of life

Outcome Measures

Primary Outcomes (1)

  • To assess the consequences of osteoporotic fractures on the rate of return to work at 3 months of active patients under 65 years of age

    Rate of patients returning to work 3 months after fracture

    Month 3

Secondary Outcomes (3)

  • To assess the consequences of osteoporotic fractures on the average return to work time of active patients under 65 years of age.

    Day 1

  • Evaluate the consequences of osteoporotic fractures on quality of life in active patients under 65

    Month 3

  • Define the predictive factors for not returning to work.

    Day 1

Interventions

All patients treated between 01/01/2017 and 12/31/2018 in the Fracture sector will be screened through the computerized medical file. For patients who meet all the eligibility criteria, the information note, study questionnaire and a stamped envelope will be sent to them by post. Without feedback from him within 30 days of this submission, the patient is considered not to have objected to the study. The patient's information as well as his non-objection will be recorded in his medical file.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients treated between 01/01/2017 and 31/12/2018 in the Fracture sector will be screened through the computerized medical file

You may qualify if:

  • Patients aged 18 to 65 at the time of the fracture
  • French-speaking patient
  • Patients treated in the Fracture Line between January 1, 2017 and December 31, 2018 for osteoporotic fracture
  • Professionally active patients at the time of the fracture

You may not qualify if:

  • Refusal to participate in the study
  • Patient under guardianship or curatorship
  • Patient deprived of liberty
  • Patient under legal protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Paris Saint-Joseph

Paris, Île-de-France Region, 75014, France

Location

MeSH Terms

Conditions

Osteoporotic Fractures

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and Injuries

Study Officials

  • Agnès PORTIER

    Fondation Hôpital Saint-Joseph

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2021

First Posted

March 4, 2021

Study Start

April 26, 2019

Primary Completion

July 15, 2019

Study Completion

September 21, 2020

Last Updated

March 9, 2021

Record last verified: 2021-03

Locations